Please JOIN: Informed Consent in Psychedelic Therapy and Research: Why is it Complicated?
Interested in Participating in our research? Please click here for a listing of our active studies.
Exploring innovative treatments for patients struggling with addiction and other illnesses
The NYU Langone Health Center for Psychedelic Medicine performs health-focused research across the translational spectrum, from basic science to large-scale clinical trials.
The NYU Langone Health Center for Psychedelic Medicine has three transdisciplinary areas of focus: psychiatry, medicine, and preclinical research. Interactive platforms of research and education span the three core areas, providing the necessary infrastructure to generate knowledge, train scientists and clinicians, and ensure accurate dissemination of information surrounding the clinical use of psychedelics.
In addition to research, our Center prioritizes education of clinicians, scientists, and the public. We have secured $5M in funding for a robust research training program that will support the development of junior faculty members and post-doctoral fellows to become independent investigators in the field of Psychedelic Medicine.
These complementary strategies promote an inclusive environment in which highly trained scientists, clinicians, trainees, and staff collaborate to ensure that the momentum created by the modern psychedelic renaissance is sustained and continues to yield medical breakthroughs backed by sound science.
News
The past 2 decades have witnessed growing interest in the clinical potential of psilocybin and other classic psychedelics to treat neuropsychiatric conditions, […]
Psilocybin Therapy Sharply Reduces Excessive Drinking, Small Study Shows
A small study on the therapeutic effects of using psychedelics to treat alcohol use disorder found that just two doses of psilocybin magic mushrooms paired with psychotherapy […]
As psychedelics treatments move closer to regulatory approval, there’s an issue looming in the industry: […]
Psilocybin Could be a Therapeutic Breakthrough For Addiction
To the uninitiated, psilocybin—the substance that gives ‘magic mushrooms’ their psychedelic qualities—could be dismissed as a recreational drug. […]
What Are Psychedelic Drugs, and How Can They Help Treat Mental Illness?
You probably know that psychedelic drugs, also called hallucinogens, affect a person’s mind by altering perceptions, moods, and thoughts. […]
How People Become Whole Through Psychedelic Therapy
Kelley O’Donnell has guided dozens of people through poignant visions and life-changing revelations. A psychiatrist and researcher, O’Donnell provides psychedelic-assisted psychotherapy at the NYU Langone Center for. […]
The New Yorker: The Trip Treatment
On an April Monday in 2010, Patrick Mettes, a fifty-four-year-old television news director being treated for a cancer of the bile ducts, read an article on the front page of the Times that would change his death. […]
NYT : A Dose of a Hallucinogen From a ‘Magic Mushroom,’ and Then Lasting Peace
On a summer morning in 2013, Octavian Mihai entered a softly lit room furnished with a small statue of Buddha, a box of tissues and a single red rose. From an earthenware chalice, he swallowed a capsule of psilocybin, […]
Read more
MindMed To Provide Funding for Psychedelic Medicine Research Training Program at NYU Langone Health and NYU Grossman School of Medicine
Contact us for more information
Learn whether you might be eligible to participate in our studies by clicking here to visit our patient participation page. Find out about opportunities to join our team by visiting our training pages. If you have other questions about our research, you can contact us by completing the form below.
The Center for Psychedelic Medicine
NYU Grossman School of Medicine
Department of Psychiatry
1 Park Ave 8th floor
462 First Avenue
A Building, 8th Floor
New York, NY 10016
PsychedelicMedicine@NYULangone.org